Efficacy of non-toxic deletion mutants of protective antigen from Bacillus anthracis

FEMS Immunology and Medical Microbiology

Volumn 45, Issue 2, 2005, Pages 341-347

  Rhie, Gi Eun ^a   Park, Young Mia ^a   Han, Ji Sun ^a   Yu, Jae Yon ^a   Seong, Won Keun ^a   Oh, Hee Bok ^a  

^a Korea National Institute of Health   (South Korea)

Author keywords

Anthrax vaccine; Bacillus anthracis; Deletion mutant; Protective antigen

Indexed keywords

ALUMINUM HYDROXIDE; AMMONIUM SULFATE; ANTHRAX VACCINE; CHYMOTRYPSIN; IMMUNOLOGICAL ADJUVANT; MUTANT PROTEIN; NEUTRALIZING ANTIBODY; PROTECTIVE ANTIGEN[163-168]; PROTECTIVE ANTIGEN[313-314]; RECOMBINANT ANTIGEN; RIBI TRIMIX; SEPHAROSE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL VIRULENCE; BACTERIUM CULTURE; CONTROLLED STUDY; CYTOTOXICITY; DELETION MUTANT; DRUG EFFICACY; FEMALE; FRACTIONATION; GEL FILTRATION; GUINEA PIG; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE;

AMINO ACID SEQUENCE; ANIMALS; ANTHRAX VACCINES; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACILLUS; BACILLUS ANTHRACIS; BACTERIAL TOXINS; BASE SEQUENCE; BINDING SITES; CELL LINE; CHYMOTRYPSIN; DNA, BACTERIAL; FEMALE; GENES, BACTERIAL; GUINEA PIGS; HUMANS; MICE; MUTATION; NEUTRALIZATION TESTS; RECOMBINANT PROTEINS; SEQUENCE DELETION; TRYPSIN;

EID: 22844433073     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.femsim.2005.05.009     Document Type: Article

References (22)

1. F.A. Beall, M.J. Taylor, and C.B. Thorne Rapid lethal effect in rats of a third component found upon fractionating the toxin of Bacillus anthracis J. Bacteriol. 83 1962 1274 1280
2. J.L. Stanley, K. Sargeant, and H. Smith Purification of factors I and II of the anthrax toxin produced in vivo J. Gen. Microbiol. 22 1960 206 218
3. C.B. Thorne, D.M. Molnar, and R.E. Strange Production of toxin in vitro by Bacillus anthracis and its separation into two components J. Bacteriol. 79 1960 450 455
4. D.M. Molnar, and R.A. Altenbern Alterations in the biological activity of protective antigen of Bacillus anthracis toxin Proc. Soc. Exp. Microbiol. Med. 114 1963 294 297
5. C. Petosa, R.J. Collier, K.R. Klimpel, S.H. Leppla, and R.C. Liddington Crystal structure of the anthrax toxin protective antigen Nature 385 6619 1997 833 838
6. M. Varughese, A.V. Teixeira, S. Liu, and S.H. Leppla Identification of a receptor-binding region within domain 4 of the protective antigen component of anthrax toxin Infect. Immun. 67 4 1999 1860 1865
7. F. Brossier, J.C. Sirard, C. Guidi-Rontani, E. Duflot, and M. Mock Functional analysis of the carboxy-terminal domain of Bacillus anthracis protective antigen Infect. Immun. 67 2 1999 964 967
8. K.R. Klimpel, S.S. Molloy, G. Thomas, and S.H. Leppla Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin Proc. Natl. Acad. Sci. USA 89 21 1992 10277 10281
9. Y. Singh, V.K. Chaudhary, and S.H. Leppla A deleted variant of Bacillus anthracis protective antigen is non-toxic and blocks anthrax toxin action in vivo J. Biol. Chem. 264 32 1989 19103 19107
10. J.C. Milne, D. Furlong, P.C. Hanna, J.S. Wall, and R.J. Collier Anthrax protective antigen forms oligomers during intoxication of mammalian cells J. Biol. Chem. 269 32 1994 20607 20612
11. T.L. Nguyen Three-dimensional model of the pore from of anthrax protective antigen. Structure and biological implications J. Biomol. Struct. Dyn. 22 3 2004 253 265
12. J.C. Milne, and R.J. Collier pH-dependent permeabilization of the plasma membrane of mammalian cells by anthrax protective antigen Mol. Microbiol. 10 3 1993 647 653
13. F.C. Belton, and R.E. Strange Studies on a protective antigen produced in vivo from Bacillus anthracis: medium and methods of production Br. J. Exp. Pathol. 35 2 1954 144 152
14. G.P. Gladstone Immunity to anthrax: protective antigen present in cell-free culture filtrates Br. J. Exp. Pathol. 27 1946 394 418
15. Rhie, G., Park, Y. M., Chung, J., Yoo, C. K., Seong, W. K. and Oh, H. B. (2005). Expression and secretion of the protective antigen of Bacillus anthracis in Bacillus brevis. FEMS Immunol. Microbiol., in press.
16. 315, in anthrax toxin protective antigen is required for translocation of lethal factor J. Biol. Chem. 269 46 1994 29039 29046
17. S. Udaka, and H. Yamagata High-level secretion of heterologous protein by Bacillus brevis Methods Enzymol. 217 1993 23 33
18. U.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature (London) 227 5254 1970 680 685
19. H. Towbin, T. Staehelin, and J. Gordon Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedures and application Proc. Natl. Acad. Sci. USA 76 9 1979 4350 4354
20. M.B. Hansen, S.E. Nielsen, and K. Berg Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill J. Immunol. Methods 119 2 1989 203 210
21. B.W. McBride, A. Mogg, J.L. Telfer, M.S. Lever, J. Miller, P.C.B. Turnbull, and L. Baillie Protective efficacy of a recombinant protective antigen against Bacillus anthracis challenge and assessment of immunological marker Vaccine 16 8 1998 810 817
22. P.C. Turnbull Anthrax vaccines: past, present and future Vaccine 9 8 1991 533 539